HCA Healthcare, Inc. (LON:0J1R)
London flag London · Delayed Price · Currency is GBP · Price in USD
377.32
+1.99 (0.53%)
At close: Jul 14, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
National Group Revenue (Post-FY2022)
19.61B
Log In
Log In
Log In
Log In
Upgrade
National Group Revenue (Post-FY2022) Growth
8.51%
Log In
Log In
Log In
Log In
Upgrade
Atlantic Group Revenue (Post-FY2022)
23.17B
Log In
Log In
Log In
Log In
Upgrade
Atlantic Group Revenue (Post-FY2022) Growth
8.20%
Log In
Log In
Log In
Log In
Upgrade
American Group Revenue (Post-FY2022)
24.60B
Log In
Log In
Log In
Log In
Upgrade
American Group Revenue (Post-FY2022) Growth
8.29%
Log In
Log In
Log In
Log In
Upgrade
Corporate & Other Revenue (Post-FY2022)
3.22B
Log In
Log In
Log In
Log In
Upgrade
Corporate & Other Revenue (Post-FY2022) Growth
-11.66%
Log In
Log In
Log In
Log In
Upgrade
National Group Revenue (Pre-FY2023)
-
Log In
Log In
Log In
Log In
Upgrade
National Group Revenue (Pre-FY2023) Growth
-
Log In
Log In
Log In
Log In
Upgrade
American Group Revenue (Pre-FY2023)
-
Log In
Log In
Log In
Log In
Upgrade
American Group Revenue (Pre-FY2023) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Corporate & Other Revenue (Pre-FY2023)
-
Log In
Log In
Log In
Log In
Upgrade
Corporate & Other Revenue (Pre-FY2023) Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBITDA by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
National Group Adjusted EBITDA (Post-FY2022)
4.43B
Log In
Log In
Log In
Log In
Upgrade
National Group Adjusted EBITDA (Post-FY2022) Growth
15.16%
Log In
Log In
Log In
Log In
Upgrade
Atlantic Group Adjusted EBITDA (Post-FY2022)
4.97B
Log In
Log In
Log In
Log In
Upgrade
Atlantic Group Adjusted EBITDA (Post-FY2022) Growth
10.29%
Log In
Log In
Log In
Log In
Upgrade
American Group Adjusted EBITDA (Post-FY2022)
5.74B
Log In
Log In
Log In
Log In
Upgrade
American Group Adjusted EBITDA (Post-FY2022) Growth
8.18%
Log In
Log In
Log In
Log In
Upgrade
Corporate & Other Adjusted EBITDA (Post-FY2022)
-1.25B
Log In
Log In
Log In
Log In
Upgrade
Corporate & Other Adjusted EBITDA (Post-FY2022) Growth
-
Log In
Log In
Log In
Log In
Upgrade
National Group Adjusted EBITDA (Pre-FY2023)
-
Log In
Log In
Log In
Log In
Upgrade
National Group Adjusted EBITDA (Pre-FY2023) Growth
-
Log In
Log In
Log In
Log In
Upgrade
American Group Adjusted EBITDA (Pre-FY2023)
-
Log In
Log In
Log In
Log In
Upgrade
American Group Adjusted EBITDA (Pre-FY2023) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Corporate & Other Adjusted EBITDA (Pre-FY2023)
-
Log In
Log In
Log In
Log In
Upgrade
Corporate & Other Adjusted EBITDA (Pre-FY2023) Growth
-
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Number of Hospitals
190.00
Log In
Log In
Log In
Log In
Upgrade
Number of Hospitals Growth
2.13%
Log In
Log In
Log In
Log In
Upgrade
Number of Freestanding Outpatient Surgery Centers
124.00
Log In
Log In
Log In
Log In
Upgrade
Number of Freestanding Outpatient Surgery Centers Growth
3.31%
Log In
Log In
Log In
Log In
Upgrade
Number of Licensed Beds
49.99K
Log In
Log In
Log In
Log In
Upgrade
Number of Licensed Beds Growth
1.70%
Log In
Log In
Log In
Log In
Upgrade
Admissions
2.24M
Log In
Log In
Log In
Log In
Upgrade
Admissions Growth
2.76%
Log In
Log In
Log In
Log In
Upgrade
Average Length of Stay (days)
4.84
Log In
Log In
Log In
Log In
Upgrade
Average Length of Stay (days) Growth
-0.75%
Log In
Log In
Log In
Log In
Upgrade
Occupancy Rate
72.70
Log In
Log In
Log In
Log In
Upgrade
Occupancy Rate Growth
2.26%
Log In
Log In
Log In
Log In
Upgrade